TASLY COMPOUND DANSHEN DRIPPING PILLS For Coronary Heart Disease 27mg*180 Pills

(No reviews yet) Write a Review
US $19.99
SKU:
BB002
Shipping:
Calculated at Checkout
Origin:
China
Form:
Pills
Adding to cart… The item has been added

Product Overview

Generic name: compound Danshen dripping pills
Chinese Pinyin: Fufang Danshen Diwan
Product name: Tasly
Ingredients: Danshen, Panax Notoginseng, Borneol.
Properties: This product is a brown film-coated dripping pill; after removing the coating, it turns yellowish-brown to brown, fragrant and slightly bitter in taste.
Functions and indications: Promoting blood circulation and removing blood stasis, regulating qi and relieving pain. It is used for chest obstruction caused by qi stagnation and blood stasis, symptoms such as chest tightness, precordial tingling; coronary heart disease angina pectoris see the above syndromes.
Specification: Each pill weighs 27mg
Usage and dosage: Orally or sublingually, 10 pills each time, 3 times a day, 4 weeks as a course of treatment; or follow the doctor's advice.
Adverse reactions: occasionally gastrointestinal discomfort.
Taboo: Not yet clear
Note: Pregnant women should use it with caution.
Drug interactions: Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: In the experiment, rats, rabbits, and mice were taken as observation objects, and they were administered by oral gavage respectively. The protective effect of this prescription on myocardial ischemia, the relaxation effect on rabbit smooth muscle, and the coronary artery of rats were observed. The influence of flow and heart rate and the influence of platelet aggregation, and acute toxicity experiments were carried out. The results found that: Compound Danshen Dripping Pills have 6 times faster effect on aortic relaxation than tablets, and are suitable for acute attacks of angina. The protective effect of dripping pills on myocardial ischemia is higher than that of tablets. With the same dose of 0.4/kg, the inhibition rate of dripping pills for stage 1 ECG abnormality is 62.5%, while that for tablets is 37.5%, and the stage 2 ECG abnormality suppression rate The rate of dripping pills is 62.5% and that of tablets is 50%. In addition, dripping pills have a better rate of increase in coronary flow than tablets, and there is no significant difference in platelet aggregation inhibition rate between dripping pills and tablets.
Storage: sealed.
Packaging: Oral solid medicinal high-density polyethylene bottle packaging, each bottle contains 180 pills.
Validity period: 48 months
Approval number: National Medicine Zhunzi Z10950111
Company Name: Tasly Pharmaceutical Group Co., Ltd.

Reviews

(No reviews yet) Write a Review